Facet Biotech Calls Biogen Idec, Inc. (Massachusetts) (JOBS) Offer Too Low; Rejects Bid
AP -- Facet Biotech Corp. on Tuesday turned down a $356 million buyout offer from drug development partner Biogen Idec Inc., saying it doesn't properly value the company and its developing products.